We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Compact Photoacoustic Sensing Instrument Enhances Biomedical Tissue Diagnosis

By LabMedica International staff writers
Posted on 15 Feb 2024
Print article
Image: The photoacoustic spectral response sensing instrument is based on low-cost laser diodes (Photo courtesy of Khan et al., doi 10.1117/1.JBO.29.1.017002)
Image: The photoacoustic spectral response sensing instrument is based on low-cost laser diodes (Photo courtesy of Khan et al., doi 10.1117/1.JBO.29.1.017002)

The pursuit of precise and efficient diagnostic methods is a top priority in the constantly evolving field of biomedical sciences. A promising development in this area is the photoacoustic (PA) technique. Over the past decade, PA imaging has gained traction as a practical imaging modality in various clinical settings where it has demonstrated encouraging results. While traditional diagnostic methods are invasive, PA imaging offers a noninvasive alternative for examining biological tissues. However, its broad clinical application has been hampered by the bulkiness and high cost of laser sources. Now, researchers have introduced a groundbreaking, compact, and affordable PA sensing instrument for biomedical tissue diagnosis. Their proof-of-concept study, utilizing cost-effective diode lasers, marks a significant step toward the transition of PA imaging from laboratory research to clinical application.

For the study, researchers from the IIT Indore (Madhya Pradesh, India) focused on the complex nature of breast tissue, specifically fibrocystic changes, which often present diagnostic challenges due to similarities with breast cancer. These changes can cause breast pain and detectable cysts and are frequently found in peritumoral breast parenchyma, complicating diagnoses. Traditional diagnostic methods like ultrasound and mammography sometimes lack the necessary precision, and fine needle aspiration cytology, a common diagnostic tool, often requires additional invasive procedures for confirmation. The PA technique, leveraging laser diodes, generates acoustic waves that provide critical insights into tissue composition and density.

The novel instrument incorporates multiple laser diodes in a compact design, coupled with a custom-built pulsed current supply unit, producing efficient PA excitation with 25 nanosecond pulses at 20 kHz. The researchers were able to distinguish between normal and diseased breast tissues by analyzing the frequency spectra of PA signals. Analyzing the frequency spectra allowed for quantitative tissue assessment. For example, fibrocystic breast disease showed a dominant frequency peak at around 1.60 MHz, suggesting increased tissue density, while normal breast tissue had a lower peak frequency of 0.26 MHz, indicative of its fibrofatty composition.

Histopathological examinations confirmed these observations, aligning spectral responses with tissue characteristics. The experimental setup differentiated tissue types based on quantitative spectral parameters, enhancing diagnostic accuracy and potentially simplifying the sampling process for pathological breast tissues. The compact PA sensing instrument could emerge as a promising tool for clinical practice, offering rapid, reliable, and cost-effective breast disease diagnosis. This breakthrough paves the way for timely interventions and improved patient outcomes, revolutionizing biomedical practices with a cost-effective and rapid tissue diagnosis approach.

Related Links:
IIT Indore

Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Nutating Mixer
Enduro MiniMix
New
Chagas Disease Test
LIAISON Chagas

Print article

Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more